Related Experiment Video
Updated: Aug 14, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Prevention of viral hepatitis in HIV co-infection
1Patrick Clements Clinic, Central Middlesex Hospital, Acton Lane, London NW10 7NS, UK. gary.brook@nwlh.nhs.uk
Abstract:
Co-infection of HIV-positive patients with hepatitis viruses worsens the long-term prognosis and this is summative for each new infection in any individual. Vaccination against hepatitis A or B may be effective but response rates are reduced in HIV infected patients. Improvement in response can be induced through extra doses, higher doses and HAART-induced increase in the CD4 count. Hepatitis B and C may also be prevented through counselling about safer sex, particularly condom use. In intravenous drug users, harm reduction, counselling and the use of needle/syringe exchange schemes may be helpful.
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly
Antiviral Nucleoside Inhibitors
